The Problem: Taxotere a chemotherapy medication used to treat breast cancer, has been linked to causing hair loss which in some cases can be permanent.
The Response: There are currently a number of lawsuits filed by women against Taxotere.
What Can We Do to Help: Our experienced attorneys can review your medical records and advise you if filing a case is in your best interest.
The attorneys at Gallon, Takacs, Boissoneault & Schaffer are investigating allegations that Taxotere (docetaxel)a chemotherapy medication used to treat cancer, most commonly breast cancer, has been linked to causing hair loss (alopecia), which in some cases can be permanent. If you or someone you know developed hair loss that appears to be permanent after taking Taxotere, contact us today. Find out if you can seek compensation for your injuries by completing our free case evaluation.
There are currently a number of lawsuits filed by women against S-A, claiming S-A failed to warn about the risk of permanent hair loss and hid studies linking the drug to toxic side effects. While alopecia is common following cancer treatments due to the nature of chemotherapy, its permanence is not.
Taxotere is administered as an IV every three weeks. It works by stopping tumorous cells from reproducing. Taxotere is produced by Sanofi-Aventis (S-A), a pharmaceutical company in France.Taxotere has been linked to causing hair loss (alopecia), which in some cases can be permanent. S-A is being accused of failing to warn both patients and doctors of these adverse affects. Up until 2015, the company assured users that hair loss would be temporary. In December 2015, the company simply removed that statement from the label. There is another, equally effective drug on the market, Taxol, which has not been linked to these adverse risks. If patients were adequately informed of these risks they may have chosen to use Taxol over Taxotere.
The FDA has not published a formal warning letter regarding permanent hair loss and Taxotere use; however they did change the label on the drug to include a warning of permanent hair loss (alopecia) in December 2015. There have been numerous FDA warnings against S-A for “false and misleading” advertisements overstating the benefits of Taxotere.
If you or a loved one have suffered permanent hair loss following the use of Taxotere for cancer treatment, contact our firm immediately at 800-GALLON1 [(800)-425-5661] or fill out a free case evaluation. We want to help you get the compensation you deserve.